IRIS
VENEZIANI, BIANCA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.221
AS - Asia 3.910
EU - Europa 3.054
SA - Sud America 419
Continente sconosciuto - Info sul continente non disponibili 153
AF - Africa 84
OC - Oceania 4
Totale 11.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.012
SG - Singapore 1.844
RU - Federazione Russa 1.174
IT - Italia 730
CN - Cina 713
VN - Vietnam 635
BR - Brasile 349
HK - Hong Kong 327
FR - Francia 272
DE - Germania 212
FI - Finlandia 153
CA - Canada 137
NL - Olanda 116
IE - Irlanda 111
GB - Regno Unito 97
UA - Ucraina 88
BD - Bangladesh 85
IN - India 79
JP - Giappone 52
MX - Messico 34
CI - Costa d'Avorio 33
SE - Svezia 29
AR - Argentina 25
IQ - Iraq 21
ZA - Sudafrica 21
PH - Filippine 18
PL - Polonia 18
ID - Indonesia 17
KR - Corea 14
TH - Thailandia 14
ES - Italia 12
PK - Pakistan 12
VE - Venezuela 12
JM - Giamaica 11
CO - Colombia 10
TR - Turchia 9
UZ - Uzbekistan 9
EC - Ecuador 8
NP - Nepal 8
SA - Arabia Saudita 7
AT - Austria 6
GT - Guatemala 6
IL - Israele 6
PY - Paraguay 6
TW - Taiwan 6
AZ - Azerbaigian 5
BE - Belgio 5
EE - Estonia 5
EG - Egitto 5
JO - Giordania 5
LT - Lituania 5
CL - Cile 4
IR - Iran 4
PT - Portogallo 4
TN - Tunisia 4
AU - Australia 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
MA - Marocco 3
MK - Macedonia 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
SV - El Salvador 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
CR - Costa Rica 2
DJ - Gibuti 2
DK - Danimarca 2
DZ - Algeria 2
HR - Croazia 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HT - Haiti 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LY - Libia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 11.686
Salva come PNG Salva come JPEG
Città #
Singapore 831
San Jose 706
Ashburn 369
Hong Kong 313
Moscow 304
Beijing 257
Chandler 209
Council Bluffs 187
Napoli 176
Hanoi 170
Ho Chi Minh City 157
The Dalles 155
Santa Clara 135
Jacksonville 122
Naples 118
Princeton 117
Dallas 115
Amsterdam 104
Lauterbourg 101
Nanjing 98
Millbury 96
Boston 91
Los Angeles 82
Ottawa 70
Wilmington 63
Munich 54
New York 51
Buffalo 50
Hefei 50
Tokyo 48
Redondo Beach 39
São Paulo 39
Haiphong 29
Nanchang 25
Rome 25
Mexico City 24
Orem 24
Des Moines 23
Milan 23
Da Nang 22
Frankfurt am Main 22
Falls Church 21
Hebei 21
Chicago 20
Norwalk 20
Dublin 19
Montreal 19
Tianjin 19
Turku 19
Woodbridge 19
Helsinki 18
Phoenix 18
Brooklyn 16
Changsha 16
Pune 16
Toronto 16
London 15
Chennai 14
Hicksville 14
Seattle 14
Shenyang 14
Warsaw 13
Brasília 12
Dong Ket 12
Houston 12
Nuremberg 12
Redwood City 12
Rio de Janeiro 12
Stockholm 12
Denver 11
Afragola 10
Manchester 10
Palma Campania 10
Belo Horizonte 9
Boardman 9
Formia 9
Jiaxing 9
Poplar 9
San Mateo 9
Thái Nguyên 9
Ann Arbor 8
Atlanta 8
Baghdad 8
Charlotte 8
Dhaka 8
Florence 8
Mumbai 8
Shanghai 8
Tashkent 8
Bangkok 7
Biên Hòa 7
Curitiba 7
Hangzhou 7
Hải Dương 7
Kunming 7
Lappeenranta 7
Seoul 7
Thái Bình 7
Can Tho 6
Elk Grove Village 6
Totale 6.390
Salva come PNG Salva come JPEG
Nome #
Progetto dimostratore di analisi dei tessuti: BIONCAM BIObanca ONcologica CAMpania 265
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 223
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 214
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 187
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 183
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 177
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 175
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status 170
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 160
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results 156
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. 151
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. 148
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review 144
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine. 144
P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib 143
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 143
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS 142
Exploring the molecular aspects associated with testicular germ cell tumors: A review 140
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells 137
AIRC Regional Grant ; “Breast cancer: preclinical and clinical development of therapeutic strategies targeting molecular mechanisms”. 136
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment 135
Epidermal growth factor receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 135
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer 133
Reti dinamiche di apprendimento a distanza 133
A banking strategy toward customized therapy in breast cancer. 130
Long-term cultures of stem/progenitor cells from lobular and ductal breastcarcinomas under non-adherent conditions. 127
Tranfected Insulin- like growth factor II modulates the mitogenic response of rat thyrocytes in culture 125
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma. 123
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B 122
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. 119
Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. 119
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 119
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. 118
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 117
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 117
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 113
Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). 113
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 110
Endogenous IGFs modulates the mitogenic response of rat thyrocites in culture. 110
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity 109
Expression of the soluble lectin L-14 gene is induced by TSH in thyroid cells and suppressed by retinoic acid in transformed neural cells. 106
Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. 102
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 101
Iodine Inhibits the Proliferation of Rat-thyroid Cells In Culture 101
INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS 101
Inibizione della proliferazione: ruolo del cAMP. 100
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity. 99
Micrornas in prostate cancer: an overview 97
Annual Meeting of the ECTS Medical Association 94
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase 94
ALTERATIONS OF AUTOPHAGIC FLUX IN CHARCOT-MARIE-TOOTH 2B DISEASE 92
“Pharmacogenetics and endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and toxicity” 91
Condroitin-6-sulfate carbohydrate units. A major source of molecular microheterogeneity of human thyroglobulin. 91
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 90
ADE-SOCRATES- Sperimentazione di e-learning su un corso di Attività Didattica Elettiva della Facoltà di Medicina e Chirurgia di Napoli “Federico II”. In: Reti dinamiche di apprendimento a distanza, U. Giani ed. Liguori Editore, pp. 345-350, 2004. ISBN: 88-207-3637-3 90
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes 90
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. 89
Endogenous IGFs modulate the mitogenic response in rat thyrocites in culture. 89
Independent and Interactive Effects of Tetradecanoyl Phorbol Acetate On Growth and Differentiated Functions of Frtl5 Cells 88
Principi di Patologia Generale 87
Ruolo di fattori di crescita autocrini nel controllo della proliferazione di cellule di tiroide di ratto in coltura. 87
Pharmacogenetics and Endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and Toxicity. 87
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 86
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 85
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 83
Dissociation and reassociation of non-covalently linked dimers of human 19S thyroglobulin treated with urea. 83
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. 83
Growth control of follicular cells in vitro. 82
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. 82
Endogenous IGF-II as a possible regulator of fetal rat thyroid gland development. 80
Realizzazione e potenziamento di laboratori pubblici nei settori delle "scienze della nutrizione", "chirurgia avanzata" e "analisi dei tessuti". 79
Circulating and disseminated tumor cells from breast cancer patient 79
Iodine inhibits the proliferation of rat thyroid cells in culture. 77
Adenosine Has Divergent Effects On Deoxyribonucleic-acid Synthesis In Frtl5 Cells - Inhibition of Thyrotropin-stimulated and Potentiation of Insulin-like Growth Factor-i-stimulated Thymidine Incorporation 77
Iodine inhibits the proliferation of rat thyroid cells. 75
TSH-EGF cooperation in the FRTL5 thyroid cell growth stimulation. 75
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review 75
Iodine inhibits the proliferation of rat thyroid cells in culture. 74
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 74
The disulfide bond pattern between fragments obtained by the limited proteolysis of bovine thyroglobulin. 73
In the thyroid cells proliferation, differentiated and metabolic functions are under the control of different steps of the cyclic AMP cascade. 73
Evidence of a biological role of an endogenous growth factor on the proliferation of rat thyroid cells. 73
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study 72
On the role of iodine on the proliferation of FRTL5 cells. 71
Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin-dependent growth of thyroid cells. 71
Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. 70
IGF endogeno e proliferazione di tireociti. 70
Oncotech 70
Short-term and Long-term Effects of Egf On Frtl5 Cells Growth 70
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches. 69
Expression of genes related to cell cycle in thyroid cells in culture. 69
Studio GIM5: Studio di correlazione tra il gene CYP19 e l’efficacia di Letrozolo in pazienti in postmenopausa con tumore della mammella 69
Epidermal Growth-factor Modulation of Tsh Mitogenic Activity 69
Epithelial-mesenchymal transition in prostate cancer: an overview 69
The tissue-specific pathways regulating cell proliferation are inherited independently in somatic hybrid between thyroid and liver cells. 68
Polyacrylamide gel electrophoresis in discontinuous transverse urea-gradient gels. 68
Sustained versus transient cyclic AMP intracellular levels: Effect on thyrotropin-dependent growth of thyroid cells 67
Expression of the Soluble Lectin L-14 Gene Is Induced By Tsh In Thyroid-cells and Suppressed By Retinoic Acid In Transformed Neural Cells 67
SRC INHIBITORS ACT THROUGH DIFFERENT MECHANISMS TO COOPERATE WITH EGFR OR MEK INHIBITORS IN NSCLC MODELS SENSITIVE OR RESISTANT TO ERLOTINIB 65
Regolazione della proliferazione e delle funzioni differenziate in mutanti di cellule tiroidee TSH-indipendenti. 64
Totale 10.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.279
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022684 0 0 0 12 28 23 22 29 117 55 116 282
2022/2023605 124 43 20 23 65 60 2 51 72 106 28 11
2023/2024475 17 58 72 38 32 56 4 41 1 5 101 50
2024/20252.774 154 167 9 52 58 128 332 136 263 306 954 215
2025/20265.135 615 374 428 379 839 252 712 297 610 338 140 151
2026/2027718 68 146 197 307 0 0 0 0 0 0 0 0
Totale 11.845